ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America (Class 5)
#4206365
Application Number:4206365
Status: DRAFT
Class:5
Applicant:GENZYME CORPORATION
Filing Date:Fri, 14 Jun 2019
In Progress
Is this your trademark application?
"ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America" is still moving through the registration pipeline. Most applications hit at least one hurdle — objection, opposition or a hearing — and deadlines at each stage are short. Get notified the moment the status changes.
Trademark Information
| Trademark | ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America |
| Trademark Type | Wordmark |
| Class | 5 |
| Application Number | 4206365 |
| Nature/Scope of business | Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections |
| Publication | In Journal No. 1913 |
| Status | DRAFT |
| Applicant: | GENZYME CORPORATION |
| Applicant Address | 50 Binney Street, CAMBRIDGE, MA 02142, United States of America a Massachusetts corporation, USA |
| Jurisdiction | DELHI |
| Agent | REMFRY & SAGAR |
| Agent Address | REMFRY HOUSE AT THE MILLENNIUM PLAZA SEC 27, GURGAON 122009, NEW DELHI NATIONAL CAPITAL REGION INDIA |
Frequently Asked Questions
What is the status of trademark ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America? ▾
The trademark application number 4206365 is currently marked as "DRAFT" in the official trademark registry.
Who is the owner of trademark ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America? ▾
The trademark application number 4206365 is owned by GENZYME CORPORATION.
Which class does trademark ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America belong to? ▾
Trademark application number 4206365 is filed under Class 5, which relates to the specified goods and services.
Who is the trademark agent for application 4206365? ▾
The trademark agent associated with application number 4206365 is REMFRY & SAGAR.
Was trademark ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America published in the journal? ▾
Yes, trademark application number 4206365 was published in Journal No. 1913.
What is trademark ZURUPTAQPriority claimed from 18/01/2019; Application No. : 88/267,149 ;United States of America? ▾
Trademark application number 4206365 relates to "Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of lysosomal storage diseases; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections".
File Trademark at Just ₹1,499 + Govt Fees
Get your trademark registered with expert guidance. Limited time offer!
File NowExpert Consultation
Quick Processing
100% Support
Free Report
Get Detailed Trademark Report
Comprehensive analysis of your trademark search delivered to your phone
What you'll get:
- Complete trademark analysis
- Conflict assessment
- Registration guidance
15,000+Trademarks Filed
98%Success Rate
Govt Authorized
ISO Certified